Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kjersti Flatmark

Showing results (111-120 of 133) with videos related to

Pageof 14
Sort By:
International Journal of Radiation Oncology, Biology, Physics|August 3, 2010
Prediction of response to preoperative chemoradiotherapy in rectal cancer by multiplex kinase activity profilingSigurd Folkvord, Kjersti Flatmark, Svein Dueland, et al.
British Journal of Cancer|April 27, 2018
Systemic immune response induced by oxaliplatin-based neoadjuvant therapy favours survival without metastatic progression in high-risk rectal cancerErta Kalanxhi, Sebastian Meltzer, Jakob Vasehus Schou, et al.
Gigascience|May 10, 2023
T cell receptor repertoire sequencing reveals chemotherapy-driven clonal expansion in colorectal liver metastasesEirik Høye, Vegar J Dagenborg, Annette Torgunrud, et al.
Cancer Immunology Research|February 27, 2019
Responsiveness to PD-1 Blockade in End-Stage Colon Cancer with Gene Locus 9p24.1 Copy-Number GainAnne Hansen Ree, Vigdis Nygaard, Hege G Russnes, et al.
NAR Cancer|January 20, 2022
A comprehensive framework for analysis of microRNA sequencing data in metastatic colorectal cancerEirik Høye, Bastian Fromm, Paul H M Böttger, et al.
British Journal of Cancer|April 25, 2024
First-line oxaliplatin-based chemotherapy and nivolumab for metastatic microsatellite-stable colorectal cancer-the randomised METIMMOX trialAnne Hansen Ree, Jūratė Šaltytė Benth, Hanne M Hamre, et al.
Annals of Surgical Oncology|July 22, 2023
Navigation-Assisted Surgery for Locally Advanced Primary and Recurrent Rectal CancerArne M Solbakken, Simen Sellevold, Milan Spasojevic, et al.
British Journal of Cancer|April 10, 2021
The circulating soluble form of the CD40 costimulatory immune checkpoint receptor and liver metastasis risk in rectal cancerSebastian Meltzer, Annette Torgunrud, Hanna Abrahamsson, et al.
Oncotarget|November 5, 2017
Molecular signatures reflecting microenvironmental metabolism and chemotherapy-induced immunogenic cell death in colorectal liver metastasesOlga Østrup, Vegar Johansen Dagenborg, Einar Andreas Rødland, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 12, 2018
Cabazitaxel-loaded Poly(2-ethylbutyl cyanoacrylate) nanoparticles improve treatment efficacy in a patient derived breast cancer xenograftMarkus Fusser, Anders Øverbye, Abhilash D Pandya, et al.
Pageof 14

Showing results (111-120 of 133) with videos related to

Sort By:
Pageof 14
International Journal of Radiation Oncology, Biology, Physics|August 3, 2010
Prediction of response to preoperative chemoradiotherapy in rectal cancer by multiplex kinase activity profilingSigurd Folkvord, Kjersti Flatmark, Svein Dueland, et al.
British Journal of Cancer|April 27, 2018
Systemic immune response induced by oxaliplatin-based neoadjuvant therapy favours survival without metastatic progression in high-risk rectal cancerErta Kalanxhi, Sebastian Meltzer, Jakob Vasehus Schou, et al.
Gigascience|May 10, 2023
T cell receptor repertoire sequencing reveals chemotherapy-driven clonal expansion in colorectal liver metastasesEirik Høye, Vegar J Dagenborg, Annette Torgunrud, et al.
Cancer Immunology Research|February 27, 2019
Responsiveness to PD-1 Blockade in End-Stage Colon Cancer with Gene Locus 9p24.1 Copy-Number GainAnne Hansen Ree, Vigdis Nygaard, Hege G Russnes, et al.
NAR Cancer|January 20, 2022
A comprehensive framework for analysis of microRNA sequencing data in metastatic colorectal cancerEirik Høye, Bastian Fromm, Paul H M Böttger, et al.
British Journal of Cancer|April 25, 2024
First-line oxaliplatin-based chemotherapy and nivolumab for metastatic microsatellite-stable colorectal cancer-the randomised METIMMOX trialAnne Hansen Ree, Jūratė Šaltytė Benth, Hanne M Hamre, et al.
Annals of Surgical Oncology|July 22, 2023
Navigation-Assisted Surgery for Locally Advanced Primary and Recurrent Rectal CancerArne M Solbakken, Simen Sellevold, Milan Spasojevic, et al.
British Journal of Cancer|April 10, 2021
The circulating soluble form of the CD40 costimulatory immune checkpoint receptor and liver metastasis risk in rectal cancerSebastian Meltzer, Annette Torgunrud, Hanna Abrahamsson, et al.
Oncotarget|November 5, 2017
Molecular signatures reflecting microenvironmental metabolism and chemotherapy-induced immunogenic cell death in colorectal liver metastasesOlga Østrup, Vegar Johansen Dagenborg, Einar Andreas Rødland, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 12, 2018
Cabazitaxel-loaded Poly(2-ethylbutyl cyanoacrylate) nanoparticles improve treatment efficacy in a patient derived breast cancer xenograftMarkus Fusser, Anders Øverbye, Abhilash D Pandya, et al.
Pageof 14